- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 11, 2025 | 258.39M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $111.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $62.37M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $8.01B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $7.86B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.83B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.88B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.24B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.96B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.28B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.23B |
| Net Income | Q1 2025 · Mar 31, 2025 | $241.51M |
| Net Income | Q1 2025 · Mar 31, 2024 | $230.05M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.82B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $19.08B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 258.48M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $73.57M |
| Capex | Q1 2025 · Mar 31, 2024 | $169.95M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $490.31M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.89 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.89 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $220.74M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $366.8M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.22B |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.07B |